Veraxa Biotech announces extraordinary shareholder meeting
VRXA•Veraxa Biotech will hold an extraordinary general meeting in Zürich on December 10, 2026, where shareholders will vote on appointing KPMG as statutory auditor for 2026, replacing resigned auditor BDO.
1. Meeting and auditor vote
Veraxa Biotech will hold an extraordinary general meeting in Zürich on December 10, 2026. Shareholders will vote on appointing KPMG as statutory auditor for the 2026 business year, replacing BDO, which has resigned.



